Consun Pharmaceutical Group
Clinical trials sponsored by Consun Pharmaceutical Group, explained in plain language.
A Chinese pharmaceutical company specializing in nephrology and dermatology products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New kidney drug candidate SK-09 enters first human safety tests Results expected Apr 2027 (estimated)